The life sciences encompass research fields that have a direct impact on our quality of our health, food and environment including pharmaceuticals, genetics, systems biology and biotechnology. Now, in the post-genomic era, the domain has undergone a revolution in terms of research approaches, new infrastructure needs and technology developments and, now more than ever, we are witnessing new developments which directly impact on our lives.
These developments are taking place throughout the world and, in order for Europe to remain competitive with the US and Asia, the necessary critical mass of expertise and resources must be made available in a coordinated manner. Currently, R & D investment is fragmented among numerous funding bodies across Europe. Now, with support from the European Commission, the ESF will launch this unique initiative to bring together these funding bodies and life sciences researchers to develop a more coordinated strategy for planning and investing in life sciences research. The establishment of EuroBioFund is well timed given that the EU’s New Seventh Framework Programme (FP7), will be launched officially as of January 1 2007, with a budget of €50 billion to invest in scientific research and innovation.
The three key objectives of the EuroBioFund are:
1. Provide a platform for funding organisations and life science researchers to foster joint research initiatives through networking and brokerage: EuroBioForum
2. Help organise research communities and facilitate bottom-up generation of research programmes of European scale and scope: EuroBioGenerator
3. Shape a new funding way in Europe by helping to develop joint investments and funding of life sciences research: EuroBioAccess
EuroBioFund’s new approach will centre on an annual conference, EuroBioForum, and the first will be held in Helsinki 14-15 December 2006. For funders this is a unique opportunity to engage with key life science research groups presenting proposals for cutting-edge pan-European research programmes. From the researcher’s side, EuroBioForum provides a forum to promote important research topics to those funding and investing in life sciences R & D.
‘Moving toward a more coordinated approach to R & D investment in the life sciences is a challenging but necessary step if Europe is to remain an important global player in life sciences and biotechnology research,’ says Wouter Spek, Director of EuroBioFund.
Wouter Spek | alfa
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences